Eton Pharmaceuticals, Inc. Amortization of Leased Asset
Eton Pharmaceuticals, Inc. (ETON) reported Amortization of Leased Asset of $20.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfLeasedAsset · last filed 2021-11-16
- Eton Pharmaceuticals, Inc. amortization of leased asset for the quarter ending 2021-09-30 was $20.00K, a 39.39% decline year-over-year.
- Eton Pharmaceuticals, Inc. amortization of leased asset for the quarter ending 2021-06-30 was $20.00K, a 39.39% decline year-over-year.
- Eton Pharmaceuticals, Inc. amortization of leased asset for the quarter ending 2020-09-30 was $33.00K.
- Eton Pharmaceuticals, Inc. amortization of leased asset for the quarter ending 2020-06-30 was $33.00K, a 44.07% decline year-over-year.
| Period end | Amortization of Leased Asset 3 month | Amortization of Leased Asset 6 month | Amortization of Leased Asset 9 month |
|---|---|---|---|
| 2021-09-30 | $20.00K 10-Q · filed 2021-11-16 | $40.00K derived: sum of 2 quarters · filed 2021-11-16 | $69.00K 10-Q · filed 2021-11-16 |
| 2021-06-30 | $20.00K 10-Q · filed 2021-08-16 | $49.00K 10-Q · filed 2021-08-16 | |
| 2020-09-30 | $33.00K 10-Q · filed 2021-11-16 | $66.00K derived: sum of 2 quarters · filed 2021-11-16 | $97.00K 10-Q · filed 2021-11-16 |
| 2020-06-30 | $33.00K 10-Q · filed 2021-08-16 | $64.00K 10-Q · filed 2021-08-16 | |
| 2019-06-30 | $59.00K 10-Q · filed 2020-08-12 | $30.00K 10-Q · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |